Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 184159
                    [Title] => US court upholds patent for drug
                    [Summary] => A US federal court recently upheld the patent for Fosomax, a blockbuster osteoporosis drug produced by Merck, a US pharmaceuticals group which was being challenged by two generic drug makers to enable them to make cheaper versions of the drug.


A Financial Times report from New York said a district court in Delaware ruled against Teva Pharmaceuticals and Ivas Pharmaceutical, two Israeli companies which were attempting to launch inexpensive versions of Fosomax. Merck’s patent on the drug, which generated $455 million in sales last quarter, is valid until August 2007.


                    [DatePublished] => 2002-11-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

TEVA PHARMACEUTICALS AND IVAS PHARMACEUTICAL

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 184159
                    [Title] => US court upholds patent for drug
                    [Summary] => A US federal court recently upheld the patent for Fosomax, a blockbuster osteoporosis drug produced by Merck, a US pharmaceuticals group which was being challenged by two generic drug makers to enable them to make cheaper versions of the drug.


A Financial Times report from New York said a district court in Delaware ruled against Teva Pharmaceuticals and Ivas Pharmaceutical, two Israeli companies which were attempting to launch inexpensive versions of Fosomax. Merck’s patent on the drug, which generated $455 million in sales last quarter, is valid until August 2007.


                    [DatePublished] => 2002-11-16 00:00:00
                    [ColumnID] => 133272
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Business
                    [SectionUrl] => business
                    [URL] => 
                )

        )

)

abtest

US court upholds patent for drug

November 16, 2002 - 12:00am

A US federal court recently upheld the patent for Fosomax, a blockbuster osteoporosis drug produced by Merck, a US pharmaceuticals group which was being challenged by two generic drug makers to enable them to make...

Business